516 related articles for article (PubMed ID: 23303847)
1. Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers.
Mawhinney E; Craig J; Morrow J; Russell A; Smithson WH; Parsons L; Morrison PJ; Liggan B; Irwin B; Delanty N; Hunt SJ
Neurology; 2013 Jan; 80(4):400-5. PubMed ID: 23303847
[TBL] [Abstract][Full Text] [Related]
2. Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers.
Campbell E; Kennedy F; Russell A; Smithson WH; Parsons L; Morrison PJ; Liggan B; Irwin B; Delanty N; Hunt SJ; Craig J; Morrow J
J Neurol Neurosurg Psychiatry; 2014 Sep; 85(9):1029-34. PubMed ID: 24444855
[TBL] [Abstract][Full Text] [Related]
3. Changing antiepilepsy drug-prescribing trends in women with epilepsy in the UK and Ireland and the impact on major congenital malformations.
Kinney MO; Morrow J; Patterson CC; Campbell E; Russell A; Smithson HW; Parsons L; Morrison PJ; Bromley R; Liggan B; Delanty N; Irwin B; Hunt SJ; Craig JJ
J Neurol Neurosurg Psychiatry; 2018 Dec; 89(12):1320-1323. PubMed ID: 29661925
[TBL] [Abstract][Full Text] [Related]
4. Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register.
Hunt S; Craig J; Russell A; Guthrie E; Parsons L; Robertson I; Waddell R; Irwin B; Morrison PJ; Morrow J
Neurology; 2006 Nov; 67(10):1876-9. PubMed ID: 17130430
[TBL] [Abstract][Full Text] [Related]
5. Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register.
Hunt S; Russell A; Smithson WH; Parsons L; Robertson I; Waddell R; Irwin B; Morrison PJ; Morrow J; Craig J;
Neurology; 2008 Jul; 71(4):272-6. PubMed ID: 18645165
[TBL] [Abstract][Full Text] [Related]
6. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations.
Holmes LB; Mittendorf R; Shen A; Smith CR; Hernandez-Diaz S
Arch Neurol; 2011 Oct; 68(10):1275-81. PubMed ID: 21670385
[TBL] [Abstract][Full Text] [Related]
7. Comparative Risk of Major Congenital Malformations With Antiseizure Medication Combinations vs Valproate Monotherapy in Pregnancy.
Cohen JM; Alvestad S; Suarez EA; Schaffer A; Selmer RM; Havard A; Bateman BT; Cesta CE; Zoega H; Odsbu I; Huybrechts KF; Kjerpeseth LJ; Straub L; Leinonen MK; Bjørk MH; Nørgaard M; Gissler M; Ulrichsen SP; Hernandez-Diaz S; Tomson T; Furu K
Neurology; 2024 Jan; 102(2):e207996. PubMed ID: 38165339
[TBL] [Abstract][Full Text] [Related]
8. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register.
Morrow J; Russell A; Guthrie E; Parsons L; Robertson I; Waddell R; Irwin B; McGivern RC; Morrison PJ; Craig J
J Neurol Neurosurg Psychiatry; 2006 Feb; 77(2):193-8. PubMed ID: 16157661
[TBL] [Abstract][Full Text] [Related]
9. Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformations.
Charlton RA; Weil JG; Cunnington MC; Ray S; de Vries CS
Drug Saf; 2011 Feb; 34(2):157-71. PubMed ID: 21247222
[TBL] [Abstract][Full Text] [Related]
10. Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India.
Thomas SV; Jose M; Divakaran S; Sankara Sarma P
Epilepsia; 2017 Feb; 58(2):274-281. PubMed ID: 28084641
[TBL] [Abstract][Full Text] [Related]
11. Antiepileptic drug combinations not involving valproate and the risk of fetal malformations.
Vajda FJ; O'Brien TJ; Lander CM; Graham J; Eadie MJ
Epilepsia; 2016 Jul; 57(7):1048-52. PubMed ID: 27265509
[TBL] [Abstract][Full Text] [Related]
12. Do Anti-Epileptic Drug modifications after first trimester of pregnancy influence fetal malformation or cognitive outcome?
Asranna A; Jose M; Philip RM; Sarma PS; Thomas SV
Epilepsy Res; 2018 Oct; 146():121-125. PubMed ID: 30098567
[TBL] [Abstract][Full Text] [Related]
13. The teratogenic risk of antiepileptic drug polytherapy.
Vajda FJ; Hitchcock AA; Graham J; O'Brien TJ; Lander CM; Eadie MJ
Epilepsia; 2010 May; 51(5):805-10. PubMed ID: 19817810
[TBL] [Abstract][Full Text] [Related]
14. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?
Montouris G; Abou-Khalil B
Epilepsia; 2009 Sep; 50 Suppl 8():16-20. PubMed ID: 19702728
[TBL] [Abstract][Full Text] [Related]
15. Malformation risk of new anti-epileptic drugs in women with epilepsy; observational data from the Kerala registry of epilepsy and pregnancy (KREP).
Thomas SV; Jeemon P; Pillai R; Jose M; Lalithakumari AM; Murali S; Sanalkumar A; Salini RA; Pavithran V
Seizure; 2021 Dec; 93():127-132. PubMed ID: 34740142
[TBL] [Abstract][Full Text] [Related]
16. Antiepileptic drug use during pregnancy: perinatal outcomes.
Kulaga S; Sheehy O; Zargarzadeh AH; Moussally K; Bérard A
Seizure; 2011 Nov; 20(9):667-72. PubMed ID: 21763158
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
Neurology; 2015 Sep; 85(10):866-72. PubMed ID: 26085607
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013
[TBL] [Abstract][Full Text] [Related]
19. The teratogenicity of the newer antiepileptic drugs - an update.
Vajda FJ; O'Brien TJ; Lander CM; Graham J; Eadie MJ
Acta Neurol Scand; 2014 Oct; 130(4):234-8. PubMed ID: 25040242
[TBL] [Abstract][Full Text] [Related]
20. Preliminary results on pregnancy outcomes in women using lamotrigine.
Tennis P; Eldridge RR;
Epilepsia; 2002 Oct; 43(10):1161-7. PubMed ID: 12366730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
